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ABSTRACT
Objectives: To estimate the prevalence, associated anomalies, and postnatal outcomes in infants prenatally diagnosed 
with ventriculomegaly. 
Material and methods: All cases of ventriculomegaly that were examined and treated by the 1st Department of Obstet-
rics and Gynecology, at the Medical University of Warsaw, from August 2007 until November 2017 were included in this 
study. Ultrasound data, and information on perinatal outcomes and long-term postnatal follow up were retrospectively 
collected by a standardised telephone survey. Ventriculomegaly was diagnosed when the atrial width of the lateral ventri-
cles was ≥ 10 mm. The cases analyzed were divided into two subgroups: isolated ventriculomegaly (IVM) and non-isolated 
ventriculomegaly (NIVM). Neurodevelopmental complications were differentiated as either moderate or severe and were 
compared within each group and between groups. 
Results: There were 118 cases of prenatally diagnosed ventriculomegaly. Complete follow up records were collected for 
54 cases (45.8%). IVM was diagnosed in 29/54 (53.7%) cases, while NIVM was diagnosed in the remaining 25 (46.3%). The 
mean ventricular width for IVM was 16.93 mm (range 10.0 mm–73.0 mm) and 14.08 mm (range 9.0 mm–27.1 mm) for NIVM 
(p = 0.28). The mean gestational age at delivery for the IVM cases was 36 + 4 weeks and in the NIVM group 33 + 4 weeks 
(p = 0.022). Mild VM (10–12 mm) was diagnosed in 22/54 cases (40.7%), moderate VM (13–15 mm) in 12/54 (22.3%) and 
severe (≥ 15 mm) in 20/54 (37%). Among the infants with IVM the rate of severe medical complications was 29.6% (8/28) 
and for NIVM 667% (8/12) (p = 0.041). Less severe medical conditions affected 6/28 of the infants with IVM (21.4%) vs 
9/12 NIVM cases (75%) (p = 0.012).
Conclusions: In terms of prenatal diagnosis, treatment of ventriculomegaly remains challenging due to a lack of specific 
prognostic factors and the significant risk of neurodevelopmental disorders. Nevertheless, isolated ventriculomegaly has 
significantly better long-term outcomes compared with non-isolated ventriculomegaly. In our material, the rate of severe 
neurodevelopmental disorders in the non-isolated ventriculomegaly cases was associated with a 52% rate of adverse 
perinatal outcomes. On the other hand, less severe medical conditions occurred in 21.4% of the infants with IVM and in 
75% of the NIVM cases. Furthermore, obstetrical data suggest that the risks of premature delivery and caesarean section 
are significantly higher in cases of non-isolated ventriculomegaly. 
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INTRODUCTION
The measurement of the posterior horns of the lateral 
ventricles has become an integral part of prenatal ultra-
sound screening. Ventriculomegaly (VM) is diagnosed when 
the atrial width is ≥ 10 mm and it remains one of the most 
common abnormalities detected prenatally. The prevalence 
range is 0.3 to 2% of foetuses [1]. To guard against false posi-
tive diagnoses, the wide variety of measurement techniques 
currently used ought to be replaced with a universal meas-
urement protocol. The diagnosis of fetal ventriculomegaly 
may be described as either idiopathic or a symptom of genet-
ic, infectious or anatomical disorders. Regardless of the pri-
mary cause, two groups may be distinguished: isolated (IVM) 
if there are no other abnormalities present, and non-isolated 
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ventriculomegaly (NIVM) where there are other abnormali-
ties present. To assess the severity of VM cases, most stud-
ies distinguish between “mild” (10–12 mm), “moderate” 
(13–15 mm) and “severe” (≥ 15 mm) ventriculomegaly [2]. 
Despite many studies undertaken by obstetricians and pae-
diatricians that investigate the natural course of VM, the 
pregnancy and long-term neurodevelopment outcomes 
remain unknown in most cases. The prognoses of fetuses 
with VM are controversial because of the large variations 
in the study scales and follow-up criteria [1]. In this study, 
we retrospectively analysed and compared pregnancy out-
comes, including long-term follow-up outcomes, in infants 
prenatally diagnosed with IVM and NIVM. 
MATERIAL AND METHODS
The total number of cases (n = 118) that were diagnosed 
with VM and examined in the 1st Department of Obstetrics 
and Gynecology, Medical University of Warsaw (Poland) 
from August 2007 until November 2017 were included in 
this study. We retrospectively collected ultrasonographic 
data, and information on perinatal outcomes and long-term 
postnatal follow up. The ultrasound scans were performed 
by experienced senior ultrasonographers using the Aloka 
Prosound Alfa 10 system with transabdominal convex probe 
and the General Electric Voluson E6 BT13.05 system with 
transabdominal volumetric probe. VM was diagnosed when 
the atrial width of the lateral ventricle was ≥ 10 mm. Once 
VM was diagnosed, a detailed scan was performed to ex-
clude associated intracranial or extracranial anomalies. The 
management protocol also included determination of ges-
tational age, measurement of the contralateral ventricle 
(in cases of an asymmetrical VM, the larger diameter was 
considered), placental site, amniotic fluid volume and esti-
mated fetal weight (according to the Hadlock formula). The 
cases were classified as “Isolated Ventriculomegaly” (IVM) if 
no associated anomaly was detected, or as “Non-Isolated 
Ventriculomegaly” (NIVM) which was defined as ultrasound 
findings of ventriculomegaly with other structural abnor-
malities or positive findings in TORCH screenings or karyo-
type examinations. 
Medical records of all cases were carefully reviewed. Tel-
ephone interviews were used to obtain information about 
pregnancy outcomes and long-term neurodevelopmental 
follow-up. All parents were asked questions based on the 
same questionnaire that included seeking information on 
the children’s: growth, neurological status, developmental 
status, locomotor activities, coordination, hearing and visual 
function, speech and socialisation capacities. Information 
on any current medical treatment or special medical care 
was also gathered.
Neurodevelopment disorders were divided into mod-
erate and severe and compared within and between the 
IVM and NIVM groups. The types of moderate and severe 
disorders analysed in this paper are presented in Table 1. 
Follow-up information and obstetrical data such as ges-
tational age at the delivery, method of delivery and birth-
weight were analysed using SPSS 15.0 (SPSS Inc., Chicago, IL, 
USA). The chi-square test was applied, and differences were 
considered to be statistically significant at p < 0.05. Descrip-
tive statistics were also used for analysis of ultrasonography 
details and the follow-up characteristics of all the cases.
RESULTS
Complete records were collected in 54 cases (45’8%). The 
high number of incomplete long-term follow-up data was 
due to inaccurate contact details in the records (i.e., either 
incorrect or missing telephone numbers). The mean ma-
ternal age at the time of the ultrasound scan was 30 years 
(range 20–45 years). Among the group of 54 fetuses af-
fected with VM, 41/54 cases were singleton pregnancies 
(75.9%) and 13/54 in twins (24.1%). The mean gestational 
age at the time of referral/diagnosis was 27+0 weeks (range 
18+0–39+2 weeks). The study group was divided into two 
subgroups: IVM (isolated ventriculomegaly) and NIVM 
(non-isolated ventriculomegaly). The IVM group consisted 
of 29/54 fetuses (53.7%) and the NIVM group consisted of 
25/54 cases (46.3%) (Fig. 1). The average gestational age at 
the time of diagnosis/counselling for IVM was 27+4 weeks 
(range: 18+6 39+2) and for NIVM, 26+1weeks (range: 18+6–
39+0). 
The mean ventricular width for IVM was 16.93 mm (range 
10.0 mm–73.0 mm) and for NIVM, 14.08 mm (range 9.0 mm–
Table 1. Types of moderate and severe complications reported in 
IVM and NIVM groups
System 
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Figure 1. Prevalence of isolated vs. non-isolated ventriculomegaly in 
the study group
Figure 2. Ventriculomegaly severity range in the study group. (Mild 
VM: 10–12 mm; moderate VM: 13–15 mm; severe VM: ≥ 15 mm)
Figure 3. Survivors in the IVM and NIVM groups
Figure 4. Prevalence of severe and moderate medical conditions 
diagnosed in the two subgroups
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only 1/29 (3.4%) postnatal death in the IVM group. A total 
of 12 of 25 (48%) NIVM fetuses survived. (Fig. 3) 
The average age of the children at the parental tel-
ephone interview was 23 months (range 6 weeks to 5 years). 
Among the surviving IVM infants, the rate of severe neu-
rodevelopmental disorders (epilepsy, tetraplegia, speech 
or hearing impairment, microcephaly, hydrocephalus, de-
layed psychomotor development) was 29.6% (8/28), and 
among the NIVM survivors, 66.7% (8/12) (p = 0.041). The 
medical complications reported in both groups are listed 
in Table 1. Less severe medical conditions, such as motor 
function disorders, autism spectrum disorders, or reduced 
or increased muscle tension affected 6/28 of infants in the 
IVM group (21.4%) vs 9/12 of the NIVM cases (75%), which 
was statistically significant (p = 0.012) (Fig. 4). 
DISCUSSION
The overall frequency of VM in the general popula-
tion is approximately 0.3–2%. Most authors classify VM ac-
cording to the three-degree classification, as either “mild” 
(10–12 mm), “moderate” (13–15 mm) or “severe” (≥ 15 mm) 
ventriculomegaly [2, 3]. In our study group, rates of mild VM 
(10–12 mm) and severe VM (≥ 15mm) were almost equal 
(40.7% and 37% respectively), while 22.3% were classified 
27.1 mm) (p = 0.28). Overall, mild VM (10–12 mm) was diag-
nosed in 22/54 cases (40.7%), moderate VM (13–15 mm) in 
12/54 (22.3%), and severe (≥ 15 mm) in 20/54 (37%) (Fig. 2).
Multiple pregnancy rates were similar in both groups 
(27.6% vs 20.0% in IVM and NIVM respectively). The 
mean gestational age at delivery for IVM was 36+4 weeks 
and in the NIVM group 33+4 weeks (p = 0.022). The rate of 
preterm delivery < 34 weeks in IVM was 6/29 (21%) and in 
NIVM 8/25 (32%), and the difference between these was 
statistically significant (p = 0.027). The mean birth weight for 
IVM neonates was 2668 g vs 2129 g for the NIVM neonate, 
which showed a borderline statistical significance (p = 0.08).
The most frequent coexisting fetal abnormalities in the 
NIVM group were agenesis of corpus callosum, spina bifida, 
hydrocephalus, subarachnoid cyst, omphalocele, ventricular 
septal defect, diaphragmatic hernia, duodenal atresia, mega 
cisterna magna, talipes, kidney agenesis, and small for gesta-
tional age. There was one case of trisomy 13 (classified as NIVM). 
Caesarean section rates in both groups were high 
amounting to 79.3% in the IVM group vs 77.3% in the NIVM 
group. The NIVM group was associated with a 52% rate of 
adverse perinatal outcomes. In 25 of the NIVM cases there 
were reported: 8/25 (32%) postnatal deaths, 2/25 (8%) still-
births, and 3/25 (12%) spontaneous abortions. There was 
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as moderate VM (13–15 mm). In a larger group of 241 fe-
tuses described by Chu et al. [1], the rate of moderate VM 
was comparable (23.2%), but in the same study the rate of 
mild VM was significantly higher that our result (62.7%). On 
the other hand, in that same paper, the rate of NIVM was 
high and reached 66% compared with 46.3% in our study 
group. Regardless of the severity of VM, follow-up scans 
are recommended as the risk of progression of ventricular 
dilatation is about 16% [4]. In most studies, progression of 
ventriculomegaly is defined as an increase in the ventricular 
measurement of more than 3 mm [5]. Several studies sug-
gested the atrial width may determine the final outcome [6]. 
However, a large meta-analysis of pooled data did not dem-
onstrate differences in the neurological outcomes between 
mild and moderate groups [4]. There is also a male pre-
dominance among fetuses with a mild VM diagnosis. It is 
noteworthy, that the female gender correlates significantly 
with worse neurodevelopmental outcomes [7].
There is wide variation in the reported incidence of 
neurodevelopmental delay, but several studies suggest this 
is around 11% [4, 7]. Weichert et al. [8] reported poor prog-
noses in 41% of cases. Another study reported handicap-free 
survival in just over one third of cases affected by severe iso-
lated VM [9]. According to several other papers, a ventricular 
atrial width of > 15 mm is related to poor outcomes [6, 10, 11]. 
A large systematic review and meta-analysis revealed abnor-
mal neurodevelopmental outcomes in 7% and 8% of mild 
and moderate VM cases, respectively, and in 58% of severe 
VM cases, suggesting the rate of neurodevelopmental delay 
for isolated mild and moderate VM is comparable to that of 
the general population [12].
We analysed 54 cases of VM diagnosed prenatally: 41 sin-
gleton (75.9%) and 13 twin pregnancies (24.1%). In a larger 
study group of 241 fetuses affected with VM, the multiple 
pregnancy rate was significantly lower than in our study 
— only 1.6% were twins [1]. The high incidence of multi-
ple pregnancies in our group may be associated with the 
specific profile of the patients, because most of them were 
referred to a tertiary ultrasound department for an expert 
opinion. Moreover, many of the twin pregnancies in our 
study group remained under prenatal surveillance in the 
Multiple Pregnancies Out Patient Unit in our Department. 
The mean maternal age in our study was 30 years, which 
was similar to that in the Gomez et al. study (29 years) [13]. 
The average gestational age at the time of delivery in the 
IVM group was significantly higher compared with that of 
the NIVM group (36+4 weeks vs. 33+4 weeks, respectively). 
This was most likely due to accompanying fetal abnormali-
ties that increase the risk of preterm delivery or premature 
rupture of membranes (PROM), such as polyhydramnios in 
the course of abnormal fetal swallowing associated with 
central nervous system defects. Discordant rates of preterm 
deliveries resulted in the differences between the mean birth 
weights (2668 g vs 2129 g for the IVM and NIVM groups, re-
spectively). Furthermore, there were surprisingly high rates of 
caesarean section in both groups — 79.3% in IVM and 77.3% 
in NIVM. A prevalence of caesarean deliveries in VM cases has 
also been reported by other authors. Hannon et al. [10] found 
an association between the final atrium measurement and 
mode of delivery with the odds of elective cesarean delivery 
being increased by 11% for each additional millimetre in atrial 
width. The most frequent indications for caesarean section in 
our group were: failure to progress, malpresentation, cepha-
lopelvic disproportion, placenta praevia and hypertensive 
disorders. It must be underscored that the VM itself is not 
an indication for caesarean section. Pisapia et. al. [14] re-
vealed that head circumference (HC) remains normal in most 
cases of VM. Only in cases with severe hydrocephaly causing 
abnormal intracranial pressure, resulting in increased head 
circumference (HC) above 400 mm, may qualify for elective 
caesarean section due to the high risk of obstetrical complica-
tions; however, there were no such cases in our study group. 
The main goal of our study was to investigate the 
long-term neurological development outcomes following 
prenatal diagnosis of ventriculomegaly. In the group of in-
fants with IVM, the rate of severe medical complications (epi-
lepsy, tetraplegia, speech or hearing impairment, microceph-
aly, hydrocephalus or delayed psychomotor development) 
was 29.6% (8/28), while in the NIVM group the rate was 66.7% 
(8/12). We found a stronger association of poor prognosis 
with coexisting fetal abnormalities (NIVM) rather than with 
atrial width alone (the mean width for IVM was 16.93 mm 
and 14.08 mm for NIVM; p = 0.28). In the literature, mortality 
and impaired neurodevelopment in infants affected with VM 
differs between obstetrical and paediatric studies. Moreover, 
neurodevelopmental delay in preschool children is not rare, 
however reliable data on its precise prevalence are limited. In 
almost 10% of cases, associated anomalies are diagnosed in 
the postnatal period. Most infants with a prenatal diagnosis 
of IVM have normal neurological development at least in 
infancy and only 11% present some abnormalities [4].
Despite numerous studies, the perinatal outcomes and 
early adolescence neurodevelopment of infants affected 
with prenatally diagnosed VM remain unknown. Several 
studies investigating perinatal outcomes in cases affected 
with VM diagnosed prenatally revealed that any associated 
defect was related to significantly worse outcomes. The 
livebirth rates in NIVM cases is about 30–40% [10, 11]. This 
is consistent with our data, as a total of 12 out of 25 (48%) 
NIVM fetuses survived. On the other hand, in our IVM group, 
neonatal death occurred in only 3.4% of cases. The high 
rate of adverse perinatal outcomes in our material may be 
associated with the low number of pregnancy terminations 
(TOP) and the decision of patients to continue the gestation. 
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A major difficulty in prenatal diagnosis and treatment 
is related to the lack of a standardized and universal defi-
nition. A ventricular diameter of 10 mm correlates with 
more than two standard deviations of the normal, hence 
it qualifies as ventriculomegaly with most authors [15, 16]. 
Unfortunately, some clinicians tend to use the terms “ven-
triculomegaly” and “hydrocephalus” synonymously. How-
ever, even severe VM and the hydrocephalic state should 
be clearly differentiated. Besides significant dilatation of 
the ventricular system, hydrocephaly is associated with 
increased intracranial pressure. Unfortunately, though it is 
not possible to measure it antenatally, some indirect signs, 
such as dangling choroid plexuses or decreased volume 
and abnormal vascular flow pattern in subarachnoid ves-
sels, may help achieve a differential diagnosis. Therefore, 
if there is no sign of increased intracranial pressure, the 
term “ventriculomegaly” should be used rather than “hy-
drocephalus”. In selected cases, fetal MRI may have an ad-
ditional diagnostic value; however, according to Malinger 
et. al., [17] a neurosonogram scan performed by an expe-
rienced sonographer has a similar accuracy to an MRI. In 
most cases neurosonography seems sufficient, especially 
with a transvaginal approach and vertex presentation, but 
MRI might be an extremely helpful imaging method in cases 
of poor visualisation or when a more detailed differential 
diagnostic tool is needed [15]. On the other hand, a large 
study involving third trimester MRI scans of 185 fetuses 
with moderate VM revealed information relevant enough 
to modify the obstetric management in 6% of cases [18]. In 
all cases of ventriculomegaly, the best available advanced 
neuroimaging should be offered as neurosonography has is 
highly accurate in the prenatal diagnosis of central nervous 
system abnormalities. It is noteworthy that approximately 
40–60% of cases of ventriculomegaly have associated CNS or 
extra-CNS abnormalities [1, 7, 19, 20]. This is consistent with 
our data — NIVM were diagnosed with CNS or extra-CNS 
abnormalities in 25/54 cases (46.3%). There are several co-
existing conditions leading to VM: meta-analysis by Gaglioti 
et al. [11] from 2009 points that abnormal turnover of cer-
ebrospinal fluid (CSF), or congenital central nervous system 
defects such as agenesis of the corpus callosum, neuronal 
migration disorders, schizencephaly, vertical transmission 
of cytomegalovirus (CMV) or toxoplasmosis, intracranial 
haemorrhage and defects of the cerebral vessels may result 
in dilatation of the ventricular system. According to the lit-
erature, 9–12% of ventriculomegaly cases have an abnormal 
karyotype [1, 21]. On the other hand, a study by Melchiorre 
et al. [4] reports the rate of chromosomal abnormalities as 
2.8%. In our group, there was only one case of trisomy 13. 
In the Melchiorre et al study, the group was screened for 
chromosomal abnormalities in the first trimester; whereas 
in our study, the single case of trisomy 13 was detected in 
the second trimester of pregnancy due to coexisting fetal 
abnormalities. 
Study limitations
Several limitations of our study should be considered. 
The study was a retrospective analysis based on ultrasound 
reports, obstetrical data and paediatric follow-up. A precise 
protocol for interviewing parents by telephone was applied 
in every case. Most likely, in the instance of a higher rate of 
postnatal follow-up our results could have shed more light 
on the prenatal diagnosis of VM. Moreover, the paediatric 
follow-up was not evaluated by a paediatric neurologist 
and the infants’ ages at the time of the telephone interview 
ranged from 6 weeks to 5 years. Considering the psychologi-
cal impact of offspring’s disease some of the data may be 
biased or inconclusive. On the other hand, this is the nor-
mal evaluation route from prenatal diagnosis to postnatal 
follow-up with retrospective studies.
CONCLUSIONS
Heterogenous aetiology and associated disorders sug-
gest that in many cases VM should be considered as a symp-
tom, not a disease itself. Despite the growing availability of 
different imaging techniques, a detailed ultrasound scan re-
mains the first step and a reliable diagnostic tool. It has to be 
underscored that the measurement technique used plays 
a crucial role in the diagnostic process. Measurement of the 
atrium of the lateral ventricles on an axial transventricular 
plane, including the frontal horns and the cavum septi pel-
lucidi, with symmetrical hemispheres is considered to be 
the most accurate [22]. Guidelines published by the Inter-
national Society of Ultrasound in Obstetrics and Gynecology 
are based on the protocol by L. Guibaud, and this seems to 
provide the highest intra-observer reproducibility [23]. Once 
VM is diagnosed prenatally, associated CNS defects should 
be excluded. The most common associated CNS defects 
are agenesis of the corpus callosum (ACC) and spina bifida. 
Due to unknown causes, prediction of postnatal neurode-
velopment in fetuses affected with VM diagnosed prenatally 
is extremely unpredictable. Unfortunately, the results of stud-
ies in both obstetrical and paediatric fields are inconclusive. 
We are not able to precisely predict long-term follow up in 
individual cases. The available severity classifications and dif-
ferentiating IVM from NIVM may help in prenatal counselling. 
Most of our results were like those available in the literature. 
Nonetheless, the obstetrical and paediatric data collected sug-
gests that only a comprehensive prenatal diagnostic approach 
will help to determine the pregnancy outcome in each case. 
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